A Single Dose of Pharmaceutical LSD Cut Anxiety Scores Five Points Below Placebo in Phase 3 Trial

A single 100-microgram dose of a pharmaceutical LSD tablet met all the main goals in a second-phase 3 anxiety trial. Regulators have not approved it.

Have A Referral?